Reuters logo
BRIEF-Cellect gets green light from FDA for ApoGraft IND submission
May 3, 2017 / 11:08 AM / 7 months ago

BRIEF-Cellect gets green light from FDA for ApoGraft IND submission

May 3 (Reuters) - Cellect Biotechnology Ltd

* Cellect gets green light from FDA for ApoGraft IND submission in the U.S.

* Cellect biotechnology - U.S. FDA provided Cellect with pre-investigational new drug meeting minutes supporting an IND submission in U.S. for ApoGraft

* Cellect Biotechnology Ltd- submission review included manufacturing (cmc) aspects, pre-clinical data and scope and design of future clinical program. Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below